Guardant Health Claimed Company
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health has commercially launched Guardant360®, Guardant360® CDx, Guardant360 TissueNext®, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer patients, and Guardant Reveal® for early-stage cancer patients. The Guardant Health screening portfolio includes the FDA-approved Shield™ blood test colorectal cancer screening. read more
HR or Marketing? Claim Your Free Employer Account
Guardant Health Investor Relations Salary
The average Guardant Health Investor Relations earns an estimated $84,233 annually. Guardant Health's Investor Relations compensation is $2,302 more than the US average for a Investor Relations.
Last updated 6 days ago.
$35k
$47k
$63k
$70k
$109k
$139k
$168k
$84,233
Average Compensation
- $84,233
- avg. base
Investor Relations Salaries at Guardant Health
Compensation at Guardant Health by Department
How Investor Relations at Guardant Health Rate Their Compensation
The majority of Investor Relations at Guardant Health believe they're not compensated fairly. 100% of Investor Relations at Guardant Health say they receive annual bonuses, and the majority (69%) are satisfied with their benefits. See more compensation ratings at Guardant Health
Investor Relations Salaries at Similar Size Companies
×